Concepedia

Philip Caron

PC

31

Publications

1.7K

Citations

21

H-Index

1975

Active since

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Cornell University

Sylvester Comprehensive Cancer Center

Columbia University

Massachusetts General Hospital

Philip Caron is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, immunology, and immunotherapy.

Top concepts

Publications per year

1975–2024

31

Publications

31

Follicular lymphoma in the modern era: survival, treatment outcomes, and identification of high-risk subgroups

Connie Lee Batlevi, Fushen Sha, Anna Alperovich et al. · Blood Cancer Journal · 2020 · 185 citations · Full text

Phase II Trial of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin as Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma

Alison J. Moskowitz, Gunjan L. Shah, Heiko Schöder et al. · Journal of Clinical Oncology · 2021 · 183 citations · Full text

Chimeric and humanized antibodies with specificity for the CD33 antigen

M S Co, N M Avdalovic, Philip Caron et al. · The Journal of Immunology · 1992 · 144 citations

Cytoreduction with iodine-131-anti-CD33 antibodies before bone marrow transplantation for advanced myeloid leukemias

John M. Burke, Philip Caron, Esperanza B. Papadopoulos et al. · Bone Marrow Transplantation · 2003 · 115 citations

, , +12

Outcomes in patients with DLBCL treated with commercial CAR T cells compared with alternate therapies

David Sermer, Connie Lee Batlevi, M. Lia Palomba et al. · Blood Advances · 2020 · 113 citations · Full text

, , +17

Rows per page

1–5 of 31